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Purpose: Optical coherence tomography angiography (OCT-A) allows noninvasive
visualization of retinal vessels in vivo. OCT-A was used to characterize the vascular
network of the mouse retina and was compared with fluorescein angiography (FA)
and histology.
Methods: In the present study, OCT-A based on a Heidelberg Engineering Spectralis
system was used to investigate the vascular network in mice. Data was compared with
FA and confocal microscopy of flat-mount histology stained with isolectin IB4. For
quantitative analysis the National Cancer Institute’s AngioTool software was used.
Vessel density, the number of vessel junctions, and endpoints were measured and
compared between the imaging modalities.
Results: The configuration of the superficial capillary network was comparable with
OCT-A and flat-mount histology in BALBc mice. However, vessel density and the
number of vessel junctions per region of interest (P ¼ 0.0161 and P ¼ 0.0015,
respectively) in the deep vascular network of BALBc mice measured by OCT-A was
significantly higher than with flat-mount histology. In C3A.Cg-Pde6bþPrph2Rd2/J
mice, where the deep capillary plexus is absent, analysis of the superficial network
provided similar results for all three imaging modalities.
Conclusion: OCT-A is a helpful imaging tool for noninvasive, in vivo imaging of the
vascular plexus in mice. It may offer advantages over FA and confocal microscopy
especially for imaging the deep vascular plexus.
Translational Relevance: The present study shows that OCT-A can be employed for
small animal imaging to assess the vascular network and offers advantages over flat-
mount histology and FA.
Introduction
The retina as part of the central nervous system
offers the unique opportunity to directly image
structural changes occurring in neurodegenerative
and neurovascular diseases such as glaucoma or
diabetic retinopathy.1,2 Several animal models of
retinal vascular diseases have provided information
about the pathogenesis and potential therapeutic
approaches such as retinal vein occlusion or oxygen-
induced retinopathy.3,4 A noninvasive imaging tech-
nique with the capability of detecting early vascular
changes, such as capillary dropout, is paramount to
develop treatment strategies for these potentially
blinding diseases in small animal models.
Ex vivo techniques such as confocal scanning laser
microscopy of retinal flat-mount specimens have been
invaluable for studying the vascular network in the
mouse but do not allow for sequential imaging. In the
last years, several new imaging techniques such as
scanning laser ophthalmoscopy have been adapted
from clinical use to study the rodent retinal vascula-
ture and to perform longitudinal studies of the retinal
vasculature in rodents.5 However, conventional im-
aging methods such as fluorescein angiography (FA)
provide only incomplete morphologic information
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about the deep vascular plexus (DVP).6,7 This
shortcoming can be overcome by spectral-domain
optical coherence tomography angiography (OCT-A)
as it combines cross-sectional intensity based struc-
tural information of the retina using high-resolution
spectral-domain OCT (SD-OCT) with information on
blood flow. High-resolution SD-OCT is able to acquire
three-dimensional (3D) images resolving the micro-
structures of the rodent retina, similar to histology.
OCT-A is increasingly used in clinics to study
microvascular pathology in various retinal diseases
and more recently it has been used for the evaluation
on choroidal neovascularization in mice.8–10 Using
OCT-A, individual retinal layers can be segmented and
therefore information on the location of microvascular
changes can be obtained.
In this study, we aimed to determine if the various
layers of the mouse retinal vasculature can be
visualized spectral-domain–based OCT-A and how
these images compare with FA (Heidelberg Spectralis
Retinal Angiography, HRA) and confocal laser
scanning microscopy of IB4 stained flat-mount
sections.
Methods
Animals
Thirteen BALB/c (wild-type inbred strain, nonpig-
mented, 4- to 6-weeks old) and two mice with an rd2
mutation (C3A.Cg-Pde6bþPrph2Rd2/J, 6-months
old) were used in this study. Mice homozygous for
the rd2, or retinal degeneration slow (rds) mutation
display a degeneration of the outer nuclear layer of
the retina beginning at 5 weeks and loss of all visual
cell structures by 12 months of age.11 Animals were
kept at the breeding facility of the Department of
Clinical Research, University Hospital of Bern, under
pathogen-free conditions in individually ventilated
cages with a standard 12-hour:12-hour light–dark
cycle with food and water available ad libitum. All
animals were treated according to the ARVO
Statement for the Use of Animals in Ophthalmic
and Vision Research and after governmental approval
according to the Federal Swiss Regulations on
Animal Welfare.
Anaesthesia was performed subcutaneously by
injecting 45 mg/kg ketamine (Ketalar 50 mg/ml;
Orion Pharma AG, Zug, Zurich, Switzerland) and
0.75 mg/kg medetomidine hydrochloride (Dormitor, 1
mg/ml; Orion Pharma AG). After image acquisition,
0.75 mg/kg atipamezole (Antisedan 5 mg/ml; Orion
Pharma AG) was given to reverse anaesthesia. The
use of medetomidine hydrochloride instead of xyla-
zine enabled us to perform the imaging, and thus no
additional anaesthetics were considered necessary.
Pupils were dilated using tropicamide 0.5% and
phenylephrine HCl 2.5% (ISPI, Bern, Switzerland).
To prevent drying or damage to the cornea due to the
lack of blinking once the mice are asleep, hydrox-
ypropylmethylcellulose (Methocel 2%; OmniVision,
Neuhausen, Switzerland) was applied to each eye
during imaging.
Imaging
In order to obtain a good view of the fundus of the
eye, mice were placed on a custom-made platform. To
prevent hypothermia, a warming patch of approxi-
mately 328C was placed between the mouse and the
platform. All images were taken and measurements
done by a SD- OCT device Heidelberg Engineering
(HRA Spectralis system; Heidelberg Engineering,
Heidelberg, Germany) using a 558 lens (Fig. 1A). A
contact lens was not used during image acquisition.
Fluorescein Angiography
As contrast agent, 0.5 mg of fluorescein (5 lL of
undiluted Fluorescein 10% Faure; Novartis, Switzer-
land; þ 45 lL water for injection) was administered
intraperitoneally 3 to 5 seconds before image acqui-
sition. Images were performed using the high-defini-
tion mode of the HRA system and a 558 lens. The
large vessels were brought into focus in the infrared
mode and a further adjustment was made after
switching to FA mode to compensate for chromatic
aberration to bring the vessels into better focus.
OCT Angiography
A Spectralis OCT-A prototype operating at 70
kHz was used. Image size of 3.83 1.9 mm (scaled for
humans and not for mice) with 13 images averaged
per scan was selected. The number of total B-scans
then calculated by the software was approximately
391 images – the distance between the B-scans was 5
to 6 lm.
Immunohistochemical Studies
After imaging, the mice were euthanized with CO2
inhalation and their eyes were removed and fixed in
4% parafolmaldehyde solution (PFA, pH 7.4) for 10
minutes. The anterior segments (cornea and lens)
were removed and the whole retina was dissected
from the eyecup and incubated for 50 more minutes in
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4% PFA. Fixed retinas were extensively washed in
0.1% Triton in phosphate buffer solution (PBS) and
incubated in blocking buffer (5% normal goat serum
[NGS] in 0.1% Triton in PBS) for 2 hours at room
temperature. Retinas were incubated in Isolectin GS-
IB4 antibody from Griffonia simplicifolia, Alexa Fluor
647 conjugate (1:100 in blocking buffer; Thermo
Fisher Scientific, Waltham, MA) at 48C for 48 hours
on a shaker, for the labelling of blood vessels. The
retinas were rinsed four more times with PBS-0.1%
Triton, four radial cuts were made and the tissues
were flat-mounted on a slide with the ganglion cell
layer facing up. Flat-mounts were cover-slipped and
observed in an inverted Zeiss LSM 710 fluorescence
confocal microscope (Carl Zeiss, Oberkochen, Ger-
many). Z-stacks of 83.2 6 36.4 lm of tissue (mean 6
standard error of the mean [SEM]) with 1 lm interval,
containing both the superficial and DVP, were
obtained and analyzed with the ZEN system 2011
software (Carl Zeiss).
Retinal Layer Segmentation to Identify
Vascular Planes
The OCT-A prototype applied the same 11-layer
segmentation algorithm as it is available for regular
OCT imaging which is able to identify reference
planes in OCT scans of healthy eyes.12 The Spectralis
OCT-A device automatically localizes the superficial
vascular plexus (SVP) between the inner limiting
Figure 1. Location of the superficial and deep plexus in the mouse retina. (A) Infrared fundus picture of the posterior pole of the mouse
eye imaged with the OCT-A device. Yellow arrows indicate the selected area of the B-scan presented in (B). (B) Automatic segmentation of
retinal layers using the Heidelberg Eye Explorer Software. The distance between the ILM and the IPL and between the IPL and the OPL
was manually measured. (C) Based on the thickness measurements in (B) manual retinal layer segmentation was possible for the
identification of the SVP (upper panel) and DVP (lower panel) located between the ILM and the outer boundary of the IPL and between
the IPL and the outer boundary of the OPL, respectively. (D) Superficial (Sp) and deep (D) vessels are also visible in histology in the same
retinal layers as described above. Arrows indicate vertical cuts of vessels in each layer. Scale bar, 100 lm.
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membrane (ILM) and the outer boundary of the inner
plexiform layer (IPL), whereas the deep retinal plexus
is localized between the outer boundary of the IPL
and the outer boundary of the outer plexiform layer
(OPL).12 Because of different dimensions in the
mouse retina some adjustments to the above men-
tioned thickness profiles were necessary and the
segmentation lines for the SVP were manually set
from the ILM to the outer boundary of the IPL,
which corresponds to approximately 60 lm (Fig.
1B).13 The DVP was defined between the IPL and the
outer boundary of the OPL (Figs. 1A–C).
In keeping with previous reports mice with a rd2
mutation had a much thinner retina (mean thickness
we measured: 72.9 lm 6 1.1 SD), and the segmen-
tation lines for the DVP were set in the area below the
IPL.11
Analysis of Vessel Density
In order to calculate vessel density we used
AngioTool software (National Institute of Health
National Cancer Institute, Gaithersburg, MD).14 To
avoid bias, the main vessels were excluded from
analysis. To assess the performance of OCT-A to
image the vascular network in the SVP and DVP we
compared OCT-A with confocal scanning laser
microscopy of flat-mount specimens stained for IB4.
With confocal microscopy, both, the superficial and
the deep plexus of the mouse retina can be differen-
tiated by scrolling through the z-stack axis providing
some 3D information of the vascular network. For
quantitative comparison of the three imaging modal-
ities we chose vessel density (%), number of endpoints
per section, and number of junctions per region of
interest. These features were analyzed separately for
both the SVP and the DVP in OCT-A and confocal
microscopy, whereas in FA we did not differentiate
individual plexi. The same area within the retina was
chosen for comparison of the imaging modalities and
a total area of 1.3 6 0.15 mm2 was measured per
image calculated from the flat-mounts.
Despite the confocality of the microscope, there
was still considerable overlay of the superficial
vasculature in the DVP. Therefore, we subtracted
the superficial vessel density from the total vessel
density obtained from confocal scanning laser mi-
croscopy.
Statistical Analysis
Data was collected in tables and statistical analysis
was then performed using Prism Graph Pad commer-
cial software (Prism 6; GraphPad Software Inc., La
Jolla, CA). Data was analyzed using unpaired t-tests.
For all analyses P less than 0.05 was considered
statistically significant. All results are presented as
mean 6 SEM.
Results
Imaging of the Retinal Vasculature Using
OCT-A in BALB/c Mice
Because of breathing movements of the anesthe-
tized mouse and the small size of the eye image
acquisition took approximately 15 minutes to per-
form imaging procedures. The mean retinal thickness
in BALBc mice was 208.16 lm 6 9.31 SD.
In BALB/c mice two distinct vascular networks
were identifiable within the retina. Decorrelation of
OCT scans (Fig. 1C) revealed vessels between the
ILM and the outer boundary of the IPL correspond-
ing to the SVP, whereas the DVP was found between
the IPL and the outer boundary of the OPL, which is
in keeping with hematoxylin and eosin histology
where vessel lumens of these two plexus can be
distinguished in between these layers (Fig. 1D). When
computing the decorrelation OCT scan as en face
images, based on concatenation of images taken in the
vertical level, the presence of these two main layers of
retinal vasculature (Figs. 2A, 2B, SVP and DVP,
respectively) was visible. Whereas the SVP and the
DVP were clearly visible in retinal flat-mounts (Fig.
2D), FA did not allow differentiating morphologic
information on individual plexi (Fig. 2C).
Quantification of Vessel Density
There was no significant difference in vessel
density, number of junctions, and endpoints (number
of open-ended segments) when analyzing the super-
ficial plexus in the OCT-A and confocal scanning
laser microscopy. However, analysis of the DVP
showed significant differences in all three features,
with all of them being significantly lower in confocal
scanning laser microscopy compared to OCT-A (Fig.
3). Because individual layers could not be differentiate
in FA and because FA only provides incomplete
morphological information on the DVP we analyzed
FA data as SVP. FA data showed a larger vessel area
than the SVP data of OCT-A or confocal scanning
microscopy (Fig. 3C). This is probably due to some
influence from the DVP.
In C3A.Cg-Pde6bþ Prph2Rd2/J mice the SVP had
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similar features as in wild-type mice in OCT-A (Figs.
4A, 4B, rd2 and wild-type mouse, respectively).
However, the DVP was absent in all of the image
acquisition modalities, which is in keeping with
published data using histology.15 Quantification of
vessel density, number of junctions, and endpoints
showed similar values in OCT-A, histology, and FA
(Fig. 4C).
Discussion
In mice and humans, the entire retina is vascu-
larized, with blood flow directed from the optic disc
radially to the periphery of the retina.16 The central
retinal artery, being supplied from the internal
carotid artery, branches in four to eight retinal
arterioles, depending on the mouse strain.17,18 The
retinal microvasculature consists of two distinct
vascular layers: a superficial capillary layer in the
nerve fiber/ganglion cell layer, and the deeper
capillary layer extending into the inner nuclear and
outer plexiform layers.19 In the mouse, it has been
shown that the superficial plexus consists mostly of
arterioles, which branch into three to four precap-
illary arterioles.20 In contrast, the DVP is predom-
inantly venous and consists of mostly capillaries.12
Recent studies have differentiated three different
vascular planes within the mouse retina, the inter-
mediate layer (within the IPL) being the connection
between the superficial and the DVP with mostly
perpendicular divisions of the vessels, and thus being
the less distinct one.20,21 In order to clearly
differentiate vessel structures of the deep and
superficial plexus we avoided placing the slabs for
the different planes too closely, and therefore did not
Figure 2. Comparison of the retinal vasculature using different imaging modalities. SVP (A) and DVP (B) of the mouse retina obtained
with OCT-A (A, B) FA (C), or confocal microscopy ([D] Scale bar, 100 lm). Red square delineates the corresponding areas of the superficial
plexus that could be visualized in all three imaging modalities (n ¼ 13).
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include the intermediate vascular plexus in our
analysis.
Visualizing the vasculature of the retina is
paramount in order to dissect the pathomechanisms
of vascular eye diseases such as retinal vein
occlusion, retinal artery occlusion, or diabetic
retinopathy. Histology has long been considered
the gold standard for assessing and quantifying
Figure 3. Analysis of different features of the retinal vasculature using the AngioTool software. (A) Vessels of the superficial (Sp, left
panel) and the deep (D, right panel) vasculature were automatically outlined using the AngioTool software, indicated by the yellow lines
surrounding the vessels. Both OCT-A (upper panel) and flat-mount (bottom panel) pictures were included. In FA images (FAG) both the
SVP and DVP were included in the quantification. (B) After the delineation of retinal vessels, the AngioTool software automatically
calculated vessel density (red lines), number of end points (blue dots indicated with dark arrows) and number of junctions (blue dots
indicated with white arrows). Scale bar, 100 lm. (C) Bar graphs were generated with GraphPad Prism and analyzed using unpaired t-tests.
No statistically significant difference was observed comparing the superficial plexus calculated from OCT-A or flat-mounts, concerning
vessels density, end points, and number of junctions. However, comparing the same values in the deep plexus we observed significant
differences between OCT-A and flat-mounts (number of junctions: P ¼ 0.0015; number of endpoints: P ¼ 0.0071), although the vessel
density showed less discrepancy (P¼ 0.0166). FA was not included in the quantification: the bar graph shows the absolute values of both
the Sp and D plexus as the layers were not separately analyzed.
6 TVST j 2016 j Vol. 5 j No. 4 j Article 11
Giannakaki-Zimmermann et al.
Downloaded From: http://tvst.arvojournals.org/pdfaccess.ashx?url=/data/Journals/TVST/935417/ on 10/04/2016
vascular changes in animal models, as well as for
judging the efficacy of potential treatments.22 Im-
munostaining of vascular endothelium with fluoro-
phore-labeled isolectin B4 in retinal flat-mounts can
highlight the overall architecture of the retinal
vessels.
However, there are many disadvantages associat-
ed with histologic processing. Because of the
inherent need to sacrifice animals to obtain histo-
logic data, a large number of animals are needed to
analyze sequential time points in a long-term study.
Quantitative assessment of the vascular network ex
vivo can be problematic due to the nonlinear
artifacts induced by fixation, postmortem ischemia,
or tissue processing. Despite excellent resolution of
confocal microscopy to image retinal vessels, the
deeper vascular networks are often difficult to
differentiate from the superficial layers. Additional-
ly, because of the interindividual variability of many
animal models of vascular diseases, it would be
desirable to test therapeutic approaches in the same
animal.23,24 In this direction, the normal vasculature
in C57BL/6J mice was recently evaluated with OCT-
A using an RTVue XR Avanti system (Optovue,
Inc., Fremont, California).10 Furthermore, this study
showed that OCT-A was useful to visualize laser-
induced choroidal neovascularization in mice. How-
ever, so far, a comparison of OCT-A findings and
histology of the retinal vasculature has not been
performed.
The principle of OCT-A is based on image
decorrelation, where particles in motion are subtract-
ed from static ones by taking a series of high speed
pictures. The inter B-scan time, which is the time that
passes between two consecutive B-scan acquisitions, is
crucial for the detection of blood flow. OCT using
split-spectrum amplitude-decorrelation angiography
(SSADA) is able to detect normal capillary flow
speeds, which have been estimated at between 0.4 and
3 mm/s and which is in the range of 1.26 6 0.34 mm/s
that has been reported in retinal vessels in mice.25–28 If
blood flow is slower than the B-scan time between
consecutive B scans, no signal can be detected at all.
In order to compare morphological features between
the three imaging modalities, we analyzed the
vascular density in the superficial and DVP using
AngioTool software.14,20 Because lateral measure-
ments using OCT have been shown to be inaccurate in
mice we were not able to use the scale bars provided in
the infrared images corresponding to the OCT
scans.29 Instead, we identified matching areas in
histology to FA and OCTA. There are no available
reports about vascular degeneration in rd2 mice.
However, similar to mice with rd1mutations the outer
nuclear layer degenerates, albeit slower than in rd1
mice.11 In rd1mice the DVP degenerates by the end of
the second postnatal week coinciding with the
degeneration of the outer retinal layers.29 Here, we
found that the DVP is absent in 6-month-old
C3A.Cg-Pde6bþ Prph2Rd2/J mice. This allowed
comparing morphological features of the SVP with-
out potential interference from the DVP.15,30 Here, we
found that all three imaging modalities provided
similar information on morphological features of the
SVP.
There are several limitations when applying OCT
devices designed for clinical use in small animal
models. Image acquisition was protracted because of
Figure 4. OCT-A imaging of C3A.Cg-Pde6bþPrph2Rd2/J mice. (A, B)
Representative images illustrate retinal thickness in C3A.Cg-
Pde6bþPrph2Rd2/J (A) mice and wild-type mice (B), respectively.
(C) Vessel area (%) in SVP of wild-type mice and C3A.Cg-
Pde6bþPrph2Rd2/J mice. No statistically significant difference in
vessel density was observed comparing FA with OCT-A or flat-mount
histology (unpaired t-test, ns, not significant).
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decreased performance of the tracking feature due
breathing artefacts. Furthermore, there are some
limitations due to the short axial length of the mouse
eye, which is only approximately 3 mm, and
therefore considerably smaller than the human
eye.31 This leads to image disparity toward the
periphery due to the higher convexity of the mouse
eye and therefore OCT-A measurements can only be
performed of the posterior pole of the mouse eye.
Another limitation inherent to OCT-A technology is
projection artifacts, where artifactual images may be
projected into deeper retinal layers than they actually
are. This may lead to a higher vessel density in the
DVP.
Lastly, because lateral measurements are inaccu-
rate in the mouse eye in OCT and infrared images, we
had to approximate regions of interests for quantifi-
cation in the three imaging modalities.
Our report combined with the recent application of
OCT-A for the evaluation of experimental choroidal
neovascularization in mice serves as a proof of
concept that OCT-A may be used to obtain in vivo
information on animal models to study retinal
vascular abnormalities following photoreceptor loss
and may provide new information on disease models
for retinal dystrophies.10
Conclusion
Our report confirms the feasibility of OCT-A
imaging in the mouse. Our results suggest that
especially for the deeper vascular network OCT-A
imaging may provide more details than confocal
microscopy, and therefore may be especially suited to
obtain new insights of vascular changes in mouse
models of retinal dystrophies, such as retinitis
pigmentosa, where the outer retinal layers are
affected.
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